Assignee
SAGIMET BIOSCIENCES INC
US·3 granted patents·5 pending applications·4 citations·filing 2017–2025
Top patents by PatentIndex Score
8 records- 0189US11622968B2Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2020·Granted Apr 11, 2023·2 cites·19 claims
- 0279US12551490B2Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2023·Granted Feb 17, 2026·0 cites·6 claims
- 0378US11034690B2Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2017·Granted Jun 15, 2021·2 cites·19 claims
- 0472US2024400552A1Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0571US2025017938A1Combination therapies of fasn inhibitors with thyroid hormone receptor agonistsSAGIMET BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0667US2026048061A1Combination therapies of fasn inhibitors with thyroid hormone receptor agonistsSAGIMET BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0761US2022340556A1Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0856US2025166821A1Methods for prediction of treatment response in non-alcoholic fatty liver diseaseSAGIMET BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →